Genetic background and evolution of relapses in aggressive B-cell lymphomas.

Abstract excerpt

Relapses of aggressive B-cell lymphomas pose a higher risk to affected patients because of potential treatment resistance and usually rapid tumor growth. Recent advances, such as targeting Bruton tyrosine kinase, have provided promising results in small numbers of cases, but treatment for the majority of patients remains challenging and outcomes are generally poor. A number of recent studies have utilized...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clonal Evolution
• Share to Disease Progression
• Share to Genetic Association Studies